PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 46 filers reported holding PAIN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $42,000 | +61.5% | 47,283 | +3.8% | 0.02% | +63.6% |
| Q4 2016 | $26,000 | -62.3% | 45,570 | -34.4% | 0.01% | -62.1% |
| Q3 2016 | $69,000 | -54.6% | 69,466 | 0.0% | 0.03% | -59.2% |
| Q2 2016 | $152,000 | -2.6% | 69,466 | -0.8% | 0.07% | -5.3% |
| Q1 2016 | $156,000 | +41.8% | 69,996 | +11.5% | 0.08% | +50.0% |
| Q4 2015 | $110,000 | -4.3% | 62,799 | 0.0% | 0.05% | -10.7% |
| Q3 2015 | $115,000 | +5.5% | 62,799 | 0.0% | 0.06% | +30.2% |
| Q2 2015 | $109,000 | -8.4% | 62,799 | -0.3% | 0.04% | +10.3% |
| Q1 2015 | $119,000 | -7.0% | 63,014 | 0.0% | 0.04% | -4.9% |
| Q4 2014 | $128,000 | -47.5% | 63,014 | +1.0% | 0.04% | -50.0% |
| Q3 2014 | $244,000 | -31.3% | 62,385 | +0.9% | 0.08% | -28.7% |
| Q2 2014 | $355,000 | -8.3% | 61,825 | -12.1% | 0.12% | 0.0% |
| Q1 2014 | $387,000 | +14.2% | 70,372 | +0.9% | 0.12% | +12.7% |
| Q4 2013 | $339,000 | +90.4% | 69,772 | +6.8% | 0.10% | +82.1% |
| Q3 2013 | $178,000 | – | 65,325 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,797,689 | $13,597,000 | 9.60% |
| SOPHROSYNE CAPITAL LLC | 1,265,020 | $6,147,000 | 5.38% |
| Madison Street Partners, LLC | 976,653 | $4,747,000 | 4.46% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 460,000 | $2,236,000 | 2.28% |
| Broadfin Capital, LLC | 1,230,000 | $5,978,000 | 0.79% |
| 683 Capital Management, LLC | 427,071 | $2,076,000 | 0.59% |
| AVALON CAPITAL MANAGEMENT | 138,520 | $673,000 | 0.57% |
| Cheyne Capital Management (UK) LLP | 92,700 | $451,000 | 0.49% |
| Visium Asset Management, LP | 4,350,000 | $21,141,000 | 0.42% |
| Gruss Capital Management LP | 789,811 | $3,838,000 | 0.29% |